Polymorphism in RIL Gene Protects Against Methylation in Cancer
Author Information
Author(s): Boumber Yanis A., Kondo Yutaka, Chen Xuqi, Shen Lanlan, Guo Yi, Tellez Carmen, Estécio Marcos R. H., Ahmed Saira, Issa Jean-Pierre J.
Primary Institution: M. D. Anderson Cancer Center, University of Texas
Hypothesis
Does a polymorphic sequence in the RIL gene influence its methylation status in cancer?
Conclusion
The study found that a specific polymorphism in the RIL gene protects against methylation, which is associated with cancer.
Supporting Evidence
- Hypermethylation of RIL correlates with loss of gene expression.
- The short allele had 2.1–3.1-fold higher methylation than the long allele.
- Electrophoretic mobility shift assays showed that the long allele binds transcription factors Sp1 and Sp3.
- Stable transfection of constructs showed that the long allele maintained expression while the short allele declined.
Takeaway
Some people have a version of a gene that helps keep it from getting too 'sticky' with a chemical that can turn it off, which is important in cancer.
Methodology
The study involved sequencing, pyrosequencing, and bisulfite sequencing to analyze methylation levels in different alleles of the RIL gene.
Potential Biases
Potential bias in sample selection and the influence of environmental factors on methylation.
Limitations
The study's findings may not fully represent in vivo conditions due to the short-term nature of in vitro assays.
Participant Demographics
The study included 326 normal samples and 240 cancer specimens, with a mix of colon cancer, MDS, and AML cases.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website